Introduction
============

The Arabian striped hyaena (*Hyaena hyaena sultana*) is the most critical large scavenger found in the tropical grassland and woodland ecosystems ([@ref-25]). The striped hyena is a carnivore with a broad head, long ears and somewhat pointed muzzle. The body slopes down from head to tail bearing black stripes on pale or pale grey underfur ([@ref-34]). Hyaenas resemble dogs in their appearance, but the skull, teeth and other anatomical resemblances bring them closer to felines. Therefore, they are placed in separate family Hyaenidae in the suborder Feliformia (cats and cat-like carnivores) and are closely related to domestic cats than dogs ([@ref-32]; [@ref-53]; [@ref-16]). *H. hyaena* is categorised as Near Threatened in the Red List of Threatened Species by IUCN ([@ref-2]). *H. h. sultana* is distributed from Oman, Saudi Arabia, and the United Arab Emirates (UAE) until Yemen; in the UAE, it was last sighted in the wild in 1996 ([@ref-18]).

Chemical immobilisation and anaesthesia is an integral component of conservation, diagnostic and surgical procedures in wild animal species ([@ref-48]). Animal capture and handling are one of the most stress-inducing events for wild animals. The effects of stress on the blood haematology and biochemistry of the animal are directly related to the capture technique employed and are much reduced in chemical capture as compared to the physical capture ([@ref-28]).

Ketamine hydrochloride has been widely used for the immobilisation of wild carnivores. It is used as an anaesthetic in combination with other drugs and has an eclectic range of benefits such as broader safety margin, low cost, high rate of absorption, lower cardiovascular and respiratory effects, and its international accessibility ([@ref-9]). However, ketamine has some disadvantages such as the requirement of a higher dose, excessive salivation, muscular hypertonicity and contractions with poor muscle relaxation, damage to retina and mydriasis, occasionally a transient and minor respiratory depression, rough inductions and recoveries, and non-availability of the antagonist ([@ref-3]). As the pharyngeal and laryngeal reflexes are not affected by ketamine, excessive salivation is not a threatening condition. However, if deemed necessary to avoid the possibility of aspiration pneumonia, salivary hypersecretion can be controlled by administration of atropine sulphate ([@ref-17]; [@ref-44]).

Ketamine combinations with α2-adrenergic agonists such as medetomidine or xylazine can reduce the dosage of ketamine, suppress its side effects and provide anxiolysis and muscle relaxation ([@ref-22]; [@ref-3]; [@ref-40]). Xylazine is an α2-adrenergic agonist that depresses the central nervous system, induces sedation and has a myorelaxation effect. The side effects of xylazine include regurgitation especially in carnivores, reduced blood pressure, heart rate and rectal temperature, excessive salivation, and may cause abortion if the female animal is pregnant ([@ref-22]; [@ref-39]; [@ref-33]). Medetomidine is a highly specific α2-adrenergic agonist that has ten times more affinity and 200 times more selectivity for adrenoceptors and induces elongated duration of analgesia and anaesthesia than xylazine ([@ref-40]). The undesired effects of medetomidine include hypertension frequently followed by peripheral hypotension, hypothermia, respiratory depression and bradycardia ([@ref-20]). The effects of medetomidine and xylazine can be reversed using potent and selective α2-adrenoceptor antagonist such as atipamezole hydrochloride. The effects of xylazine can also be reversed using yohimbine hydrochloride ([@ref-20]; [@ref-16]).

Spotted hyaena have been immobilised successfully with ketamine at a dosage rate of 7--15 mg/kg ([@ref-41]), xylazine one mg/kg with one mg/kg phencyclidine ([@ref-54]), zoletil four mg/kg ([@ref-46]), xylazine 10.7 ± 1.9 mg/kg with ketamine 0.5 ± 0.1 mg/kg ([@ref-45]) and ketamine four to six mg/kg with xylazine one mg/kg ([@ref-16]) in numerous studies. However, the references on the immobilisation of Arabian striped hyaena are scarce. In the present study, we investigated the two combinations of ketamine with xylazine and medetomidine and assessed the quality of induction, anaesthesia, and recovery stages along with the effects of these drugs on the physiological and clinical parameters through monitoring of vital signs, blood haematology, biochemistry, blood gas analysis and behavioural response of the animals to immobilisation.

Materials and Methods
=====================

Study area
----------

The study was conducted in Sir Bani Yas Island, which is 250 km West of Abu Dhabi and is 87 km^2^ (8,700 hectares) in size. The entire island is protected; an Arabian Wildlife Park consisting of 4,100 ha which was developed in 2009. Roughly over 16,000 individuals belonging to various species inhabit the island, with 2.5 million planted trees providing a suitable habitat to the animals ([@ref-11]).

Study animals
-------------

A total of 15 (six males and nine females) (semi-) captive adult *H. h. sultana*, with an average weight and standard error of 31.39 ± 0.36 kilograms, were managed under conservation breeding project at the island. A total of 50 immobilisations (ketamine-medetomidine (KM): *n* = 34 and ketamine-xylazine (KX): *n* = 16) were performed on these 15 animals as part of routine animal management and veterinary interventions for vaccinations (necessary protocol for the whole collection) and translocations. Additionally, 18 immobilisations were performed for treatments from January 2014 till March 2018 on Sir Bani Yas Island, UAE ([Table 1](#table-1){ref-type="table"}). The animals were free roaming in 4,100 ha park or were housed in enclosures of an average size of 0.57 ± 0.16 ha (mean ± SE). The animals and protocols (KM or KX) were randomly selected by using simple random sampling ([@ref-43]). However, due to a shortage of xylazine during the study, more immobilisations had to be performed with KM combination. The 18 immobilisations of injured animals with KM combination, rated as ASAPS Class 2E according to American Society of Anaesthesiologists ([@ref-12]), were excluded from the analysis due to biased numbers of patients, as a single patient (out of four patients) received 12 out of 18 treatments and pre-anaesthesia excitement and trauma affecting the quality of induction, anaesthesia and recovery phases. All the immobilisations were performed according to the highest animal care and management standards and institutional animal health care and management plan (BFM-WL-CI/0017-2014). No patient was explicitly selected for study purposes; therefore, ethical committee approval was not required.
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###### Details of investigated animals and reasons for immobilisation of *Hyaena hyaena sultana* immobilised with Ketamine-Medetomidine and Ketamine-Xylazine combinations in (semi-) captive conditions.

![](peerj-07-7326-g002)

  Animal ID    Sex      Age     Average weight (kg) ± SE   Number of immobilisations   Health condition/reasons for immobilisation (*n*)
  ------------ -------- ------- -------------------------- --------------------------- ---------------------------------------------------
  Aramis       Male     Adult   34.50 ± 3.37               3                           HV
  Arnold       Male     Adult   36.70 ± 3.20               5                           TL (1); HV (4)
  Athos        Male     Adult   30.85 ± 0.73               3                           HV
  Bravo        Male     Adult   31.10 ± 1.63               5                           TL (1); HV (4)
  Buwaytir     Male     Adult   29.85 ± 1.23               3                           TL (1); HV (2)
  Porthos      Male     Adult   30.17 ± 1.83               3                           TL (1); HV (2)
  Alpha        Female   Adult   28.83 ± 1.43               3                           TL (2); HV (1)
  Chips        Female   Adult   31.13 ± 1.01               4                           TL (1); HV (3)
  D'Artagnan   Female   Adult   30.70 ± 0.89               5                           TL (1); HV (4)
  Dopey        Female   Adult   30.83 ± 1.48               3                           HV (3)
  Gadget       Female   Adult   30.57 ± 1.43               3                           HV
  Luna         Female   Adult   32.43 ± 0.57               2                           HV
  Phiri        Female   Adult   29.65 ± 1.22               5                           TL (2); HV (3)
  Sirius       Female   Adult   34.00 ± 0.00               1                           HV
  Starsky      Female   Adult   31.25 ± 0.75               2                           TL

**Note:**

TL, translocations; HV, health check and vaccination.

Chemical restraint
------------------

The animals were darted either from a vehicle or a hiding trailer depending on the conditions, ensuring that the animal was not excited prior to the drug delivery. Due to the high temperatures in the region, all the immobilisations were either early morning or late evening. The ideal darting site was hindquarters. However, depending on the orientation of the animal, the neck area was also found suitable ([@ref-16]). The intramuscular (IM) drug injection was executed through Dan-Inject CO~2~ Injection Rifle (No. 0471, Model JM) using a dart syringe of three ml with a plain (1.5 × 20 mm) Dan-Inject needle. To avoid data biasness, it was made sure that all injections were completely delivered IM so that a second dart or supplementary dosage was not required. It was made sure that the animals were not near their burrows while roaming in 4,100 ha area and the burrows were closed in the smaller enclosures to halt the entry of drugged animals into the burrows. In the two combinations, the drugs used were ketamine hydrochloride (Ketamil Injection), medetomidine hydrochloride (Ilium Medetomidine Injection), and xylazine hydrochloride (Ilium Xylazil---100) from Troy Laboratories, Australia. The target dosage in KM was 2.33 mg/kg and 0.04 mg/kg, while five mg/kg and one mg/kg for KX calculated from literature for hyaena species ([@ref-23]; [@ref-16]). The drug dosages were calculated by visual weight estimation and previous weighing records of the animals according to [Table 2](#table-2){ref-type="table"}, whereas the actual weight was measured using a portable weighing scale and actual administered drug dose was calculated ([@ref-15]; [@ref-26]). Once the procedure was finished, the effects of α2-adrenergic agonist were reversed using atipamezole hydrochloride (Ilium Atipamezole Injection; Troy Laboratories, Glendenning, NSW, Australia), or yohimbine hydrochloride (Reverzine^TM^ Injection; Bayer, Pymble, NSW, Australia). Xylazine is usually reversed with yohimbine, but it was not available during some of the immobilisations, and we had to work with the opportunity in line with institutional and veterinary requirements at those times. Therefore, partial reversals of KX combination were with atipamezole and partial with yohimbine. The observers recording vital signs, quality of anaesthesia, and taking and processing blood samples were double-blinded to avoid biases.
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###### Dosage of drug agonists and antagonists in two combinations for the immobilisation of *Hyaena hyaena sultana* immobilised with Ketamine-Medetomidine and Ketamine-Xylazine combinations in (semi-) captive conditions.
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  Combinations                   Drugs      Concentration (mg/ml)   Mean dosage ± SE (mg/kg)   Standard dose (ml)
  ------------------------------ ---------- ----------------------- -------------------------- --------------------
  Ketamine + Medetomidine (KM)   Ketamine   100                     2.27 ± 0.044               0.7
  Medetomidine                   1          0.04 ± 0.001            1.3                        
  Atipamezole (Reversal)         5          0.21 ± 0.003            1.3                        
  Ketamine + Xylazine (KX)       Ketamine   100                     4.95 ± 0.115               1.5
  Xylazine                       100        0.99 ± 0.023            0.3                        
  Atipamezole (Reversal)         5          0.09 ± 0.003            0.6                        
  (or) Yohimbine (Reversal)      10         0.23 ± 0.006            0.7                        

Duration and quality of the anaesthesia
---------------------------------------

The time was recorded from the delivery of dart until induction and later anaesthesia and recovery. After the induction animal was approached silently and was checked for the state of anaesthesia by touching it through a bamboo stick. If there was no response, the animal was placed in a lateral position as they have a simple stomach, and in the lateral position, their respiration remains effective ([@ref-23]). The chemical restraint procedure was divided into three categories viz. induction, anaesthesia and recovery. For each category, times in minutes for different events were recorded. For induction, the times from injection of anaesthetics to the time of first sign of the drug taking effect (ataxia), sternal position, head down and completion of induction were recorded. Anaesthesia period was considered the duration in which animal had sufficient loss of body movements or sudden jerks, the absence of pedal and palpebral reflexes, no muscle tone and no response to an external stimulus such as injections and sample collection and was calculated as the time from the completion of induction till administration of the reversal. The reversal was administered when the animals exhibited the signs of drugs being metabolised and losing their effects, such as pedal of palpebral reflexes, ear twitching, and grunting sounds. For recovery, the times were recorded for the duration from the administration of reversal till first sign of consciousness (ear twitching, blinking of eyes, retraction of the tongue), lifting head up, going to sternal position and complete recovery ([@ref-15]; [@ref-26]). The quality of induction, anaesthesia and recovery were assigned a numerical score from 1 (excellent) to 4 (unsatisfactory) as described by [@ref-26]. The description for each score is presented in [Table 3](#table-3){ref-type="table"}.

10.7717/peerj.7326/table-3

###### Scoring Table for Induction, Immobilisation Quality and Recovery for immobilisation of *Hyaena hyaena sultana* immobilised with KM and KX combinations (modified from [@ref-26]).
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  Score   Quality          Induction                                                                                                                                                      Anaesthesia                                                                                                                                                                         Recovery
  ------- ---------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       Excellent        Quick and smooth induction; absence of uncoordinated movement, stereotypic reaction, ptyalism, vomiting, and discomfort at the injection site                  The absence of body movement, pedal and palpebral reflexes, muscle tone, response to an external stimulus                                                                           Quick and smooth recovery; absence of uncoordinated movement, ptyalism, vomiting, quick retraction of the tongue
  2       Good             Quick induction but resistance to loss of balance, slight ptyalism, pacing, and licking                                                                        Ear twitching, no muscle tone, occasional (\<3 times) pedal and palpebral reflexes, occasional body twitching to an external stimulus                                               Quick recovery, slight struggle to balance, slight ptyalism, licking, and slightly weak coordination in hindquarters
  3       Satisfactory     Moderate or Slow induction, pacing more than 50 m, ptyalism, slight discomfort at the injection site, panting and grunting                                     Ear and limb twitching, slight muscle tone, delayed pedal and palpebral reflexes, slight twitching to an external stimulus                                                          Slow recovery, delayed retraction of the tongue, Ptyalism, struggle in standing and uncoordinated movements, erection of mane hair
  4       Unsatisfactory   No induction or violent resistance, vomiting, panting, stereotypic pacing, grunting, excessive ptyalism, severe discomfort to the injection site and licking   Body movement, limb withdrawn, grunting sounds, increased muscle tone, blinking, twitching of ear, immediate pedal and palpebral reflexes, rapid response to an external stimulus   Delayed recovery, inability to retract tongue, gain balance and no palpebral reflexes, unable to stand, temporary loss of sensation in the hindquarter, shivering

**Note:**

The scoring for induction, immobilisation and recovery was assessed separately based on observations at each stage during an immobilisation procedure.

Monitoring of the vital signs
-----------------------------

During anaesthesia phase, the rectal temperature, pulse rate, respiration rate, non-invasive blood pressure, capillary refill time, and blood oxygen saturation (SpO~2~) were recorded at 5-min intervals ([@ref-21]; [@ref-26]). Changes in body temperature were measured through rectal thermometer (NOVAMED Digital thermometer, Surrey, England, UK) and rectal thermometer probe of the pulse oximeter (Purescope Veterinary Patient Monitor IP-3000/4000 Series; Infunix Technology Co., Ltd., Seoul, South Korea). Pulse rate was monitored by cardiac auscultation and by a pulse oximeter to cross-verify by manual observations ([@ref-21]). Respiration rate was monitored manually through direct observation of the movement of the thoracic cavity. The blood oxygen level was measured through pulse oximeter with the probe placed at the tongue of the animals. Systolic and diastolic non-invasive blood pressure was measured through pulse oximeter by placing the cuff on the median palmar artery (proximal to the metacarpal pad) as instructed in the operational manual of the monitor (Infunix Technology Co., Ltd., Seoul, South Korea). Capillary refill time was assessed by pressing the oral mucosa through thumb and then counting the required seconds to regain its colour ([@ref-26]).

Blood gas analysis
------------------

The blood was taken from the femoral artery after 15 min into the anaesthesia and immediately analysed using I-Stat handheld blood gas analyser (iSTAT^®^ 1, Abbott Laboratories, Lake Bluff, IL, USA) and i-STAT^®^ CG8+ Cartridge. The variables that were measured included pH, partial pressure of carbon dioxide, partial pressure of oxygen (pO~2~), blood concentrations of sodium, potassium, glucose (Glu) and ionised calcium (iCa), total carbon dioxide, bicarbonate, base excess, haematocrit (Hct), haemoglobin (Hb), and haemoglobin oxygen saturation (sO~2~) ([@ref-26]). Due to lack of available reference range for parameters mentioned above, feline range provided with the test kit was used as hyaenas are more closely related to felids, especially their physiological responses to xylazine and ketamine ([@ref-53]; [@ref-16]; [@ref-1]).

Blood haematology and biochemistry analysis
-------------------------------------------

Blood biochemistry and haematology was performed on the blood samples drawn from the jugular vein using 20 ml disposable syringes. Blood (six to eight ml) was collected in serum gel tubes for blood biochemistry, three to four ml in heparin lithium tubes for cortisol hormone, and three to four ml in EDTA K~3~ tubes for haematology. The blood in the serum gel and heparin tubes was centrifuged at 2,000 rpm for 3--5 min and 1,000 rpm for 2--3 min, respectively. The samples were either analysed using Abbott CELL-DYN^®^ 3700 Haematology Analyser or Abbott Architect c4000 clinical chemistry analyser; or through Central Veterinary Research Laboratory (paid services). The study variables included; red blood cells count (RBC), Hb, packed cell volume (PCV), mean cell volume, mean cell haemoglobin (MCH), platelets, white blood cell count (WBC), neutrophils, lymphocytes, monocytes, eosinophils, basophils, creatinine kinase, lactate dehydrogenase (LDH), calcium (Ca), phosphorus (PHOS), aspartate transferase (AST), alanine transferase (ALT), alkaline phosphate (ALP), total bilirubin, creatinine (CREA), blood urea nitrogen, total protein (TP), albumin, uric acid, triglycerides, cholesterol, α-Amylase, Glu, and cortisol. The parameters mentioned above were compared to the references ranges of striped hyaena provided in ZIMS by Species 360.

Data analyses
-------------

The recorded data for vital signs (*n* = 34 for KM and *n* = 16 for KX); blood gas and clinical biochemistry analyses (*n* = 21 for KM and *n* = 16 for KX) were assessed through Shapiro--Wilk test for normal distribution and then were analysed through general linear model using STATISTICA software, with main effects, individuals as random, combination and sex were fixed.

Results
=======

All 50 immobilisation events were successful with both combinations at induction, anaesthesia and recovery phases. The quality of induction was between excellent and good with the mean score and standard error (MS ± SE) 1.41 ± 0.10 and 1.31 ± 0.12 in KM and KX, respectively. The quality of anaesthesia was excellent in KM (1.00 ± 0.00) as compared to KX, where it was scored as good (2.0 ± 0.0). The recovery of the animals in KM was between excellent and good (1.76 ± 0.15), whereas, the quality of recovery in KX was between good and satisfactory (2.69 ± 0.12), especially reversing with yohimbine (3.00 ± 00) as compared to atipamezole (2.50 ± 0.17).

The time variables of both combinations for different stages of immobilisation are provided in [Table 4](#table-4){ref-type="table"}. There was a significant difference amongst the two combinations for anaesthesia time (*F* = 5.1; *P* \< 0.05), time to stand after administration of reversal (*F* = 8.3; *P* \< 0.05) and complete recovery (*F* = 7.9; *P* \< 0.05). Moreover, there was a significant difference between the sexes in the time to lift the head (*F* = 4.2; *P* \< 0.05) and time to stand after administration of reversal (*F* = 6.2; *P* \< 0.05). Females took less time compared to males. However, we could not establish any reason why females were quicker to lift the head and stand compared to males, and there was no significant difference in time to full recovery between the sexes. The two reversing agents for KX showed a significant difference in time to full recovery (*F* = 529.0; *P* \< 0.05).
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###### Time variables of various chemical restraint stages for *H. h. sultana* immobilised with Ketamine-Medetomidine and Ketamine-Xylazine combinations in (semi-) captive conditions.
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  Time variables                                                         KM (n = 34)    KX (n = 16)    *F* statistics for factors with *P* \< 0.05
  ---------------------------------------------------------------------- -------------- -------------- ---------------------------------------------
  Time to first sign (ataxia)[^\*^](#table-4fn1){ref-type="fn"}          4.56 ± 0.40    4.19 ± 0.33    --
  Time of sternal position[^\*^](#table-4fn1){ref-type="fn"}             6.15 ± 0.65    5.75 ± 0.39    --
  Time of head down[^\*^](#table-4fn1){ref-type="fn"}                    6.80 ± 0.65    6.87 ± 0.43    --
  Induction time[^\*^](#table-4fn1){ref-type="fn"}                       10.12 ± 0.65   9.37 ± 0.45    --
  Anaesthesia time                                                       59.5 ± 2.41    49.25 ± 1.31   *F*~DRUG~ = 5.1
  Time to first reversal sign[^+^](#table-4fn2){ref-type="fn"}           1.94 ± 0.22    2.13 ± 0.35    --
  Time to head up[^+^](#table-4fn2){ref-type="fn"}                       3.70 ± 0.56    4.13 ± 1.13    *F*~SEX~ = 4.2
  Time to sternal position (Reversal)[^+^](#table-4fn2){ref-type="fn"}   4.03 ± 0.54    5.63 ± 1.09    --
  Time to stand[^+^](#table-4fn2){ref-type="fn"}                         4.91 ± 0.60    10.38 ± 1.48   *F*~DRUG~ = 8.3; *F*~SEX~ = 6.2
  Time to complete recovery[^+^](#table-4fn2){ref-type="fn"}             12.32 ± 1.37   21.25 ± 2.16   *F*~DRUG~ = 7.9

**Notes:**

Time from administration of anaesthetics

Time from administration of reversal.

The mean variations of pulse rate, respiration rate, systolic and diastolic non-invasive blood pressure, blood oxygen saturation and rectal temperature throughout anaesthesia are presented in [Fig. 1](#fig-1){ref-type="fig"}. The capillary refill time for all immobilisations was less than 2 s. There was no significant difference in the vital signs between males and females (*P* \> 0.05). However, Rectal temperature, pulse rate, respiration rate and blood oxygen saturation were significantly different (*F* = 7.5, 6.4, 6.8 and 4.6, respectively, with *P* \< 0.05) between the combinations ([Table 5](#table-5){ref-type="table"}).

![Comparison of mean variation of vital signs during anaesthesia of *Hyaena hyaena sultana* using combinations of Ketamine-Medetomidine and Ketamine Xylazine in (Semi-) Captive conditions; (A) pulse rate; (B) respiration rate; (C) N.I.B.P. systolic; (D) N.I.B.P. diastolic; (E) Blood SpO~2~; (F) rectal temperature.](peerj-07-7326-g001){#fig-1}
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###### Comparison of physiological variables of vital signs and blood gas analysis during chemical restraint of *H. h. sultana* immobilised with KM and KX combinations in (semi-) captive conditions.
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  Vital sign variables   Units                                       Range               KM (*n* = 34) Mean ± SE   KX (*n* = 16) Mean ± SE   F statistics for factors with *P* \< 0.05
  ---------------------- ------------------------------------------- ------------------- ------------------------- ------------------------- -------------------------------------------
  Rectal temperature     °C                                          --                  37.58 ± 0.29              36.00 ± 0.68              *F*~DRUG~ = 7.5
  Pulse rate             Beats/min                                   --                  50.46 ± 1.90              61.14 ± 2.79              *F*~DRUG~ = 6.4
  Respiration rate       Breaths/min                                 --                  29.44 ± 0.99              23.80 ± 1.57              *F*~DRUG~ = 6.8
  SpO~2~                 \%                                          --                  89.59 ± 1.34              82.06±3.92                *F*~DRUG~ = 4.6
  N.I.B.P (Systolic)     mmHg                                        --                  145.36± 2.13              141.16±3.66               --
  N.I.B.P (Diastolic)    mmHg                                        --                  106.74± 1.97              102.43± 3.50              --
                         **Range[\*](#table-5fn2){ref-type="fn"}**   **KM (*n* = 21)**   **KX (*n* = 16)**                                   
  pH                     --                                          7.25--7.40          7.28 ± 0.01               7.26 ± 0.01               --
  pCO~2~                 mmHg                                        33.0--51.0          45.94 ± 1.02              46.79 ± 2.08              --
  HCO~3~^−^              mmol/l                                      13.0--25.0          21.73 ± 0.67              22.22 ± 0.67              --
  TCO~2~                 mmol/l                                      16--25              22.81 ± 0.65              23.19 ± 0.61              --
  BE                     mmol/l                                      (−5)--(+2)          −5.52 ± 0.69              −5.94 ± 0.38              --
  pO~2~                  mmHg                                        90--110             53.00 ± 2.54              44.44 ± 3.08              *F*~DRUG~ = 5.9
  sO~2~                  \%                                          \>90                80.57 ± 2.39              69.44 ± 5.09              --
  Na^+^                  mmol/l                                      147--162            144.38 ± 0.25             143.50 ± 0.43             --
  K^+^                   mmol/l                                      2.9--4.2            4.35 ± 0.07               4.17 ± 0.08               --
  iCa^++^                mmol/l                                      1.20--1.32          1.43 ± 0.01               1.45 ± 0.02               --
  Hct                    \% PCV                                      24--40              38.33 ± 0.96              39.88 ± 0.93              --
  Hb                     g/dl                                        8.0--13.0           12.98 ± 0.32              13.21 ± 0.31              --

**Notes:**

SE for measurements of rectal temperature, pulse rate and respiration rate in an animal immobilised once (*n* = 1) indicates SE of five repeated/consecutive measurements during one immobilisation event. pH, potential of hydrogen; pCO~2~, partial pressure of carbon dioxide; pO~2~, partial pressure of oxygen; BE, base excess; HCO~3~, bicarbonate; TCO~2~, total carbon dioxide; sO~2~, oxygen saturation; Na^+^, sodium; K^+^, potassium; iCa^++^, ionised calcium; Hct, haematocrit; Hb, haemoglobin.

Feline range from I-Stat reference manual for CG8+ Cartridge.

The blood gas analysis results showed no statistically significant difference between sexes or drug combinations except pO~2~ that had statistically significant difference among combinations (*F* = 5.9, *P* \< 0.05). The comparison of variables from blood gas analysis to the range value of felines suggested that most of the variables remained within described range except ionised Calcium (iCa^++^) which was high; pO~2~ and sO~2~ were low.

The results of the clinical variables are given in [Table 6](#table-6){ref-type="table"}. The statistical analysis of the variables between sexes showed a significant difference in platelet count, WBC, LDH and cortisol levels (*P* \< 0.05). There was also a statistically significant difference between the combinations for MCH, PHOS, ALT, ALP, CREA, TP, Glu, α-Amylase, and cholesterol (*P* \< 0.05). The mean values were compared with the range of values of striped hyaena extracted from ZIMS by Species 360, to assess the condition of the animals. All the variables were within the described range ([Table 6](#table-6){ref-type="table"}).
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###### Comparison of clinical variables during chemical restraint of *H. h. sultana* immobilised with Ketamine-Medetomidine and Ketamine-Xylazine combinations in (semi-) captive conditions.
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  Variables     Units            Range[\*](#table-6fn1){ref-type="fn"}   KM (*n* = 21)   KX (*n* = 16)    *F* statistics for factors with *P* \< 0.05
  ------------- ---------------- --------------------------------------- --------------- ---------------- ---------------------------------------------
  RBC           10^12^ cells/l   4.54--9.80                              7.38 ± 0.13     7.11 ± 0.21      --
  Hb            g/dl             9.8--17.6                               15.39 ± 0.27    14.72 ± 0.43     --
  PCV           l/l              --                                      0.45 ± 0.01     0.43 ± 0.02      --
  MCV           fl               8.3--73.4                               61.20 ± 0.77    60.21 ± 0.91     --
  MCH           pg               15.8--24.6                              21.29 ± 0.16    20.56 ± 0.20     *F*~DRUG~ = 6.04
  MCHC          g/dl             28.4--38.1                              34.70 ± 0.60    34.21 ± 0.68     --
  PLT           10^9^/l          --                                      223.33 ± 6.3    210.75 ± 9.26    *F*~SEX~ = 6.05
  IRON          μmol/l           --                                      17.9 ± 1.04     18.94 ± 1.37     --
  WBC           10^9^/l          5.4--17.1                               8.15 ± 0.22     7.15 ± 0.40      *F*~SEX~ = 13.7; *F*~INDIV~ = 2.6
  NEU           \%               53.6--88.5                              70.30 ± 1.70    64.94 ± 1.83     --
  LYM           \%               6.9--38.0                               25.57 ± 1.67    30.42 ± 2.10     --
  MONO          \%               0.9--10.6                               3.59 ± 0.31     2.79 ± 0.25      --
  EOS           \%               0.0--8.0                                2.21 ± 0.62     1.81 ± 0.54      --
  BASO          \%               0.0--3.6                                0.02 ± 0.01     0.11 ± 0.07      --
  CK            U/l              53--567                                 143.8 ± 10.9    262.0 ± 73.38    --
  LDH           U/l              394--1810                               579.8 ± 19.4    585.25 ± 28.18   *F*~SEX~ = 7.4
  Ca            mmol/l           2.0--2.8                                2.48 ± 0.02     2.44 ± 0.02      *F*~INDIV~ = 3.08
  PHOS          mmol/l           0.60--1.70                              1.48 ± 0.04     1.26 ± 0.03      *F*~DRUG~ = 28.8
  AST/GOT       U/l              41--113                                 102.3 ± 7.16    99.56 ± 7.48     --
  ALT/GPT       U/l              21--91                                  46.57 ± 2.54    37.25 ± 3.87     *F*~DRUG~ = 8.08
  ALP           U/l              10.0--48.0                              15.05 ± 1.09    12.88 ± 0.49     *F*~DRUG~ = 4.9
  TBIIL         μmol/l           0.0--6.8                                1.11 ± 0.10     1.38 ± 0.09      --
  CREA          μmol/l           62--150                                 82.76 ± 2.94    92.56 ± 4.52     *F*~DRUG~ = 5.4
  BUN           mmol/l           3.9--13.4                               11.89 ± 1.01    11.54 ± 0.47     --
  TP            g/l              53--74                                  67.52 ± 0.64    64.94 ± 0.44     *F*~DRUG~ = 9.6
  ALB           g/l              15--32                                  29.95 ± 0.49    30.63 ± 0.43     --
  Glu           mmol/l           3.5--12.1                               8.03 ± 0.46     9.99 ± 0.60      *F*~DRUG~ = 4.4
  α-Amylase     U/l              346--911                                694.5 ± 22.3    519.13 ± 21.80   *F*~DRUG~ = 15.9
  Cholesterol   mmol/l           3.8--11.0                               5.16 ± 0.22     4.16 ± 0.15      *F*~DRUG~ = 13.7; *F*~INDIV~ = 2.6
  UA            μmol/l           0--36                                   9.48 ± 0.44     8.06 ± 0.49      --
  TG            mmol/l           0.4--2.2                                1.44 ± 0.23     1.22 ± 0.07      --
  Cortisol      nmol/l           --                                      477.4 ± 43.9    475.13 ± 54.23   *F*~SEX~ = 8.9

**Note:**

Reference range for striped hyaena extracted from ZIMS by Species 360. RBC, red blood cell count; Hb, haemoglobin; PCV, packed cell volume; MCV, mean cell volume; MCH, mean cell haemoglobin; PLT, platelets; IRON, iron; WBC, white blood cell count; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, eosinophils; BASO, basophils; CK, creatinine kinase; LDH, lactate dehydrogenase; Ca, calcium, PHOS, phosphorus; AST, aspartate transferase; ALT, alanine transferase; ALP, alkaline phosphate; TBIL, total bilirubin; CREA, creatinine; BUN, blood urea nitrogen; TP, total protein; ALB, albumin; Glu, glucose; UA, uric acid; TG, triglycerides.

Discussion
==========

Chemical restraint with KX and KM combinations and their effects on the physiological and clinical parameters of Arabian striped hyaena are reported for the first time in the current study. With both combinations, the immobilisation was achieved rapidly for handling and execution of desired procedures such as vaccination, translocation or treatment according to described dosages ([Table 2](#table-2){ref-type="table"}). It is incredibly essential that carnivores especially hyaenas assume quick induction due to their affinity to enter a burrow, hide, run deep into the forest or mountainous area, or intraspecific aggression and safety of both humans and animals. Quick induction for the immobilisation of wild animals facilitates monitoring of animals, reduction of injuries, stress, hyperthermia; and chances of animal escape or hiding ([@ref-16]; [@ref-5]).

Ketamine is regarded as a general anaesthetic that has analgesic activity and no cardiopulmonary depression but has poor muscle relaxation and high excitatory state in animals with excessive salivation when administered alone. The amnestic and anaesthetic effects of ketamine are caused due to overstimulation and disruption of the nervous system. Ketamine alone is not recommended, especially in canids due to its over-excitatory effects and prolonged recoveries ([@ref-49]).

We required a lower dosage of ketamine than recommended (2.5--3.0 mg/kg) for carnivores with KM ([@ref-20]). The actual dosage for ketamine in the current study for KM was 55% lower than the KX, suggesting that medetomidine is highly effective in enhancing the potency of ketamine. It could be attributed to the high affinity and selectivity of medetomidine to adrenoceptors than xylazine ([@ref-40]). Therefore, a lower dosage of ketamine was required that enhanced the quality of immobilisation by lowering the side effects of ketamine as well as enhancing reversal quality as ketamine does not have a reversal. Studies on snow leopard also suggested a reduction of ketamine doses up to 25% ([@ref-20]).

The addition of ketamine also enhances the effect of medetomidine, which produces sedation depending on its dose and requires high dosage for complete immobilisation. The dosage of medetomidine (0.04 ± 0.001 mg/kg) was lower than the recommended dosage (0.06--0.1 mg/kg) for carnivores ([@ref-20]) but was within the recommended dose for hyaena ([@ref-23]). Moreover, the dosage of ketamine in KX was closer (4.95 ± 0.115 mg/kg and) in the current study compared to that used in hyaenas (5--10 mg/kg) ([@ref-23]). The xylazine dose (0.99 ± 0.023 mg/kg) in our combination was within the dosage range of 0.5--1.0 mg/kg for spotted hyaena and 1.0 mg/kg for jaguar ([@ref-9]; [@ref-23]; [@ref-7]).

Due to high potency, suppression of norepinephrine in the nervous system, reduced emetic effects, longer sedative and analgesic duration of medetomidine, it is preferred over xylazine ([@ref-31]). The pharmacokinetics of medetomidine reveal its rapid absorption and distribution due to its high lipophilic characteristics ([@ref-20]). KM combination was found more effective in anaesthesia and recovery phases compared to KX combination according to the scoring system provided in [Table 3](#table-3){ref-type="table"}.

The induction with both combinations was between excellent and good, giving smooth induction, the absence of stereotypic reactions, with no to little ptyalism and resistance to loss of balance. However, there was a single case of vomiting with KX that can be related to xylazine being emetic in Hyaenidae and other carnivores ([@ref-8]; [@ref-16]). The studies on donkeys, captive cougars, Southern river otters, free-ranging African lions, and marmosets had excellent to good scores using ketamine with medetomidine or other drugs such as xylazine ([@ref-36]; [@ref-42]; [@ref-51]; [@ref-4]; [@ref-26]; [@ref-27]). The quality and depth of the anaesthesia were excellent with KM combination providing deep anaesthesia, no body movements or sudden jerks, the absence of pedal and palpebral reflexes, no muscle tone and no response to an external stimulus such as injections and sample collection. It could be attributed to the clinical analgesic, sedative and myrelaxation properties of medetomidine in felids and canids ([@ref-20]). The good quality of anaesthesia was similarly reported in marmosets using KM, wild dogs using KM with atropine, and wild leopards using KX ([@ref-50]; [@ref-6]; [@ref-4]). On the other hand, KX combination provided good anaesthesia with occasional ear and body twitching, pedal and palpebral reflexes to the external stimuli ([@ref-30]; [@ref-49]). Occasional body movements are associated with the effects of ketamine when used in combination with xylazine. With both combinations, good myorelaxation was achieved to even perform dental examination ([@ref-30]; [@ref-20]; [@ref-49]). The average anaesthesia time in both combinations was higher as compared to the described useful anaesthesia time ([@ref-20]). The study on Golden-headed tamarinds, however, showed that the combination of dexmedetomidine with ketamine provided higher quality and duration of anaesthesia compared to KM ([@ref-37]).

Residual motor impairment is apparent when a higher dosage of ketamine in KX and KM combinations are used in carnivores, leading to ataxic recoveries ([@ref-20]). Recovery in KM combinations was between excellent and good. The animals were quick to recover, without vomiting, and with quick retraction of the tongue, slight struggle to balance, slight ptyalism and occasionally weak coordination in hindquarters. Due to the lower dosage of ketamine in KM, the animals were able to recover smoothly and quickly. The recovery in KX combination was mostly satisfactory providing slow recovery, delayed retraction of the tongue, ptyalism, weak coordination or uncoordinated movements and erection of mane.

The reversals with atipamezole were more effective as compared to yohimbine, which coincides with the study of [@ref-20], who described a rapid reversal with atipamezole; as it has a high alpha-2/alpha-1selectivity ratio of 8,526 compared to 40 of yohimbine. Moreover, yohimbine is known only to partially antagonise the effects of xylazine, leading to delayed recoveries ([@ref-31]). Atipamezole also showed a significant difference in time to full recovery and produced shorter recovery times compared to yohimbine. The times to arousal or first reversal sign with both combinations were markedly shorter than that in snow leopards (9 min) ([@ref-20]). It is essential in wild conditions where the post-anaesthetic period for animals is very crucial as they can be a victim of aggression from other conspecifics that reversal is quick and smooth ([@ref-33]).

The respiration rate in KX was lower than KM; as ketamine causes dose-dependent respiratory depression due to an imbalance of muscarinic---nicotinic cholinergic activity of the brain centre ([@ref-20]). The respiration was occasionally shallow and fast during the middle of anaesthesia compared to the whole duration in KX, and with time, the respiratory rate decreased in both combinations. The respiratory depression is associated with α2-adrenergic agonist and ketamine may ameliorate the respiratory depression when used with medetomidine ([@ref-29]; [@ref-14]). KM provided a stable respiratory pattern throughout the immobilisation.

Both xylazine and medetomidine are known to cause initial oxygen depression and increased CO~2~ and subsequent compensation in cats and snow leopards ([@ref-20]). The blood oxygen saturation monitored by oximeter indicated a significant difference between the combinations with KX showing signs of hypoxaemia. The blood gas analysis also indicated severe hypoxaemia with KX combination, although, KM was also below the described range. Oxygen supplementation is essential and useful intervention when working with KX and KM on Arabian hyaenas. Blood gas analysis revealed mild metabolic acidosis. In wild felids, the metabolic acidosis is supposed to be normal due to their high dietary protein intake ([@ref-13]; [@ref-51]).

Hypoxaemia is a complication commonly associated with wildlife immobilisation, especially when animals are breathing normal air ([@ref-52]). α2-adrenergic agonists are known to depress the respiratory centres and sensitivity to carbon dioxide in many species. The administration of xylazine has shown central hypoxaemia due to pulmonary alterations ([@ref-10]). Hypoxaemia can be a serious complication if coupled with hyperthermia and may lead to the death of the animal if not compensated ([@ref-52]). However, there was no case of hyperthermia recorded with studied combinations.

The pattern of rectal temperature fluctuation during the anaesthesia ([Fig. 1](#fig-1){ref-type="fig"}) reveals that the temperature starts to decrease in animals sedated with KM and slightly increases in KX which coincides with the reported disadvantages of xylazine that causes loss of thermoregulatory control and causes hyperthermia ([@ref-20]; [@ref-14]). In the current study, no case of hyperthermia was recorded, and the rectal temperature in both combinations was within the reported range ([@ref-16]; [@ref-35]). It is incredibly essential to administer KX when the external temperatures are not high, and animals are not subjected to undue physical exertion and stress; as external temperatures and prolonged chasing before dart can cause hyperthermia ([@ref-20]).

Bradycardia is an intrinsic symptom with the agonist of α2-adrenoceptors, especially medetomidine ([@ref-20]; [@ref-14]; [@ref-51]). The heart rate was significantly lower in KM as compared to KX, but the means with both combinations were within the described range for hyaenas. Both combinations showed slight signs of bradycardia during the later phases of immobilisation, where the heart rate decreased gradually but not below the normal range. When ketamine is used with xylazine, it suppresses the bradycardic effect of xylazine through cardiotonic action reconciled by vagolytic action ([@ref-7]). The administration of anticholinergic drugs such as atropine is reported to reduce bradycardia and salivation in hyaenas when immobilised with KX ([@ref-16]). However, in the current study, we did not administer atropine. Additionally, ventricular arrhythmias are reported in dogs and wolves when atropine is used with KM ([@ref-24]). Another prominent effect of medetomidine is hypotension that is marked with an initial increase and then hypo- or normotension that was also observed in the current study ([@ref-20]).

Although, medetomidine is known for its adrenolytic properties where PCV decreases due to pooling of RBCs in the spleen ([@ref-20]); the erythrocytes, PCV and Hct values were within the prescribed range for striped hyaena in the current study. α2-adrenergic insulin inhibition in the beta cells of the pancreas and higher production of Glu in the liver frequently causes hyperglycaemia with medetomidine. Moreover, in tigers higher dosage of xylazine caused hyperglycaemia ([@ref-20]). No hyperglycaemia was observed in our studies. The clinical analysis of blood also showed that there was no chronic kidney or liver disorder as ketamine is not recommended for renal or hepatic dysfunctional patients ([@ref-20]). Cortisol levels were significantly higher in females. In spotted hyaena, the cortisol levels in adult or dominant females are usually higher than males and female cubs ([@ref-47]). The mean cortisol level for both sexes was higher compared to the reported values for spotted hyaena (87.96 ± 74.03 ng/ml and 101.83 ± 71.79 ng/ml for males and females, respectively). It suggests a response to immobilisation stress during the initial phases of the immobilisation. Due to unavailability of samples at the later stages of immobilisation, it is difficult to assess whether the initial stress to capture was suppressed or not ([@ref-47]; [@ref-38]).

The limitations of the study included lack of data on effects of oxygen supplementation to the tested combination for compensation of hypoxaemia, and samples for cortisol at later stages of immobilisation, and unavailability of yohimbine and xylazine during the study that led to more immobilisations with KM.

Conclusions
===========

In conclusion, we found KM combination more suitable for the immobilisation of Arabian striped hyaena, providing better quality and timings of induction, anaesthesia and recovery as compared to KX. KX also provided, in general, adequate immobilisation of the animals and can be alternatively used with the provision of supplementary oxygen, as complication of hypoxaemia was common in both combinations. However, certain other parameters with KX, especially time to full recovery can be critical if there are other animals around and can harm the recovering individual. We found severe hypoxaemia with KX, although there was hypoxaemia in KM to some extent. It urges a further study with the provision of supplementary oxygen to assess its effectiveness in the reduction of hypoxaemia. Other limitations included unavailability of yohimbine and xylazine during the study that led to more immobilisations with KM.
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